The Effects of Antenatal Stress on the Newborn in Medically Assisted Reproduction: the SARA Study
概览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- IRCCS Eugenio Medea
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Maternal Depression
概览
简要总结
The goal of this observational longitudinal study is to examine the association between prenatal psychological and biological stress and neonatal health outcomes in couples who conceived through medically assisted reproduction. The study includes expectant mothers and fathers during pregnancy and at birth and focuses on pregnancies achieved through homologous fertilization and heterologous fertilization via oocyte donation.
The main questions this study aims to answer are:
- How do psychological and biological indicators of stress manifest during pregnancy in women who have undergone medically assisted reproduction?
- Is prenatal maternal stress associated with neonatal health outcomes independently of genetic factors?
- How does perceived stress present in expectant fathers during pregnancy? Researchers will compare couples who conceived through homologous fertilization with couples who conceived through heterologous fertilization via oocyte donation to understand whether associations between prenatal maternal stress and neonatal outcomes are independent of shared genetic background.
Participants will:
- Complete a remote eligibility assessment collecting information on pregnancy characteristics, parental health, and maternal psychological well-being
- Complete online questionnaires at multiple time points during pregnancy and at birth assessing anxiety and depressive symptoms, perceived social support, and self-efficacy (both parents), as well as pregnancy-specific measures and prenatal bonding (mothers only)
- In late pregnancy, mothers will collect saliva samples at home over two consecutive days to assess biological markers of stress (cortisol and alpha-amylase)
详细描述
This observational, longitudinal, and multidisciplinary study investigates how prenatal psychological and biological stress affects neonatal outcomes in couples who conceived through medically assisted reproduction. The study employs a cross-fostering design, comparing mother-infant diads who are genetically related with those who are not. This allows researchers to distinguish the effects of prenatal stress from genetic influences. Data from this study may also be compared with findings from a previous study by our research group ("EDI Study"; Nazzari et al., 2019, 2020a, 2020b) for common objectives. The study is non-commercial and conducted on a not-for-profit basis.
Participants are recruited through fertility centers, where physicians present the study to prospective parents during routine visits, supported by brochures and informational materials.
Mothers undergo an initial screening using the Quick SCID-5 to exclude psychiatric disorders other than anxiety and depression, and complete a health questionnaire to assess physical status during pregnancy.
Eligible mothers and fathers then participate in several phases of data collection throughout pregnancy and at birth. Both parents complete online questionnaires assessing anxiety, depressive symptoms, perceived social support, and general self-efficacy. Mothers additionally complete pregnancy-specific measures, including the NuPDQ to evaluate prenatal distress and the Pre EA-SR to assess prenatal emotional availability and bonding with the fetus. In the third trimester, mothers also collect saliva samples at three points during the day across two consecutive days to measure stress-related biological markers (cortisol and alpha-amylase).
At birth, neonatal outcomes-including gestational age, weight, length, head circumference, and any perinatal complications-are recorded. Mothers also provide information about the impact of medically assisted reproduction on daily life and the psychological support they received during pregnancy.
The enrollment period for each participant lasts approximately 8 months, from recruitment in the first two months of pregnancy until childbirth. The overall study duration is 36 months.
Data analysis will employ multiple regression and hierarchical linear models to account for both primary and secondary outcomes and handle missing data appropriately.
This study will provide valuable insights into how prenatal stress manifests behaviorally, psychologically, and physiologically in parents who have undergone assisted reproduction and how it relates to neonatal outcomes. Findings could inform early interventions to support families in these populations from the very first stages of pregnancy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Pregnant women in the first trimester and their respective partners.
- •Pregnancy achieved through homologous assisted reproduction techniques.
- •Pregnancy achieved through heterologous assisted reproduction via oocyte donation.
- •Singleton pregnancy.
- •Pregnancy achieved through FIVET techniques.
排除标准
- •Parents under 18 years of age.
- •Pregnancy achieved through heterologous assisted reproduction via donor sperm.
- •Pregnancy achieved without FIVET techniques.
- •Maternal hypertension during pregnancy.
- •Endocrine or immune system disorders during pregnancy.
- •Chronic use of medications during pregnancy (including anti-inflammatory drugs, antidepressants, or steroids).
- •Alcohol or substance abuse.
- •Smoking during pregnancy.
- •Psychiatric disorders other than anxiety or depression.
- •Pregnancy or perinatal complications.
研究组 & 干预措施
Homologous fertilization group
Mother shares genetic heritage with the child
干预措施: Diagnostic procedures (Other)
Heterologous fertilization group
Mother does not share genetic heritage with the child (oocyte donation)
干预措施: Diagnostic procedures (Other)
结局指标
主要结局
Maternal Depression
时间窗: Assessed in the 1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth.
Levels of depressive symptoms in mothers during pregnancy and at birth, measured using the EPDS
Maternal salivary cortisol
时间窗: 3rd trimester (34th-36th week of pregnancy)
Salivary cortisol levels measured at three time points across two consecutive days in late pregnancy, reflecting HPA axis
Maternal Anxiety
时间窗: Assessed in the 1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth.
Levels of anxiety in mothers during pregnancy and at birth, measured using the STAI
Maternal salivary alpha amylase
时间窗: 3rd trimester (34th-36th week of pregnancy).
Salivary alpha-amylase levels measured at three time points across two consecutive days in late pregnancy, reflecting sympathetic nervous system activity.
Paternal Anxiety
时间窗: 1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth
Levels of anxiety during pregnancy and at birth measured using the STAI
Paternal depression
时间窗: 1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth.
Levels of depressive symptoms in fathers during pregnancy and at birth, measured using the EPDS
Neonatal Outcomes
时间窗: At birth
Gestational age, birth weight, length, head circumference, and any perinatal complications recorded at birth.
次要结局
- Pregnancy-Specific Distress (maternal)(1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week))
- Prenatal Emotional Availability(1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week))
- Perceived Social Support(1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth.)
- Parental Self-Efficacy(1st trimester (11th-13th week), 2nd trimester (22nd-24th week), 3rd trimester (34th-36th week), and at birth.)
- Infertility-Related Experiences and Psychological Support(3rd trimester (34th-36th week)